In severe, uncontrolled asthma, tezepelumab reduced exacerbations and improved asthma control at 1 y

被引：3
作者：
Taleb, Ali A. [1 ]
Badgett, Robert G. [1 ]
机构：
[1] Univ Kansas, Sch Med, Wichita, KS 67214 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2021年 / 174卷 / 10期
关键词：
D O I：
10.7326/ACPJ202110190-115
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：JC115 / JC115
页数：1
相关论文
共 50 条
  • [21] Determinants of asthma control and exacerbations in moderate to severe asthma
    Chan, Rory
    Lipworth, Brian J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (10) : 2858 - +
  • [22] Characteristics of Asthma Exacerbations That Required Hospitalization in Patients with Severe, Uncontrolled Asthma Receiving Tezepelumab Compared with Placebo: Results from the Phase 3 NAVIGATOR Study
    Ambrose, C. S.
    Cook, B.
    Roseti, S. L.
    Gelhorn, H.
    Cutts, K.
    Lindsley, A. W.
    Colice, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [23] Positioning of Tezepelumab in Severe Asthma
    Miralles-Lopez, J. C.
    Antolin-Amerigo, D.
    Garcia-Moguel, I
    Dominguez-Ortega, J.
    Delgado-Romero, J.
    Quirce, S.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2024, 34 (01) : 1 - 11
  • [24] Tezepelumab can restore normal lung function in patients with severe, uncontrolled asthma
    Pavord, Ian Douglas
    Brightling, Christopher E.
    Korn, Stephanie
    Martin, Nicole
    Ponnarambil, Sandhia
    Molfino, Nestor A.
    Parnes, Jane R.
    Cook, Bill
    Ambrose, Christopher S.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [25] TEZEPELUMAB EFFICACY ACCORDING TO BRONCHODILATOR REVERSIBILITY IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA IN NAVIGATOR
    Menzies-Gow, A.
    Bourdin, A.
    Korn, S.
    Cook, B.
    Ambrose, C.
    Ponnarambil, S.
    Hunter, G.
    Molfino, N.
    Colice, G.
    Llanos-Ackert, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S37 - S37
  • [26] Tezepelumab (Tezspire) for Severe Asthma
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1644): : 25 - 26
  • [27] Effect of tezepelumab on healthcare utilization in patients with severe, uncontrolled asthma The NAVIGATOR study
    Menzies-Gow, Andrew
    Bourdin, Arnaud
    Chupp, Geoffrey
    Israel, Elliot
    Hellqvist, Asa
    Hunter, Gillian
    Roseti, Stephanie L.
    Ambrose, Christopher S.
    Llanos, Jean-Pierre
    Cook, Bill
    Corren, Jonathan
    Colice, Gene
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (03) : 343 - +
  • [28] Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR 
    Laidlaw, Tanya M.
    Menzies-Gow, Andrew
    Caveney, Scott
    Han, Joseph K.
    Martin, Nicole
    Israel, Elliot
    Lee, Jason K.
    Llanos, Jean-Pierre
    Martin, Neil
    Megally, Ayman
    Parikh, Bhavini
    Vong, Sylvia
    Welte, Tobias
    Corren, Jonathan
    JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 : 915 - 932
  • [29] Tezepelumab for Patients with Severe Uncontrolled Asthma: A Systematic Review and Meta-Analysis
    Zoumot, Zaid
    Al Busaidi, Nasser
    Tashkandi, Wail
    Aljohaney, Ahmed A.
    Isse, Said
    Vidyasagar, Kota
    Ukwaja, Kingsley Nnanna
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 1665 - 1679
  • [30] Long-term safety and efficacy of tezepelumab in adolescents with severe, uncontrolled asthma
    Brusselle, Guy
    Cook, Bill
    Lawson, Kaitlyn
    Ponnarambil, Sandhia
    Lindsley, Andrew
    Stolz, Daiana
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
12345